|
Signs of inflammation
|
US + clinical assessment
|
US only
|
Clinical assessment only
|
Joints with no signs of inflammation on US or clinical assessment
|
Number of joints examined
|
Agreement: US versus clinical assessment (%)
|
|---|
|
MCP 2nd
|
23
|
12
|
3
|
22
|
60
|
45 (75)
|
|
MCP 3rd
|
20
|
10
|
5
|
25
|
60
|
45 (75)
|
|
MCP 4th
|
8
|
11
|
2
|
39
|
60
|
47 (78)
|
|
MCP 5th
|
8
|
16
|
2
|
34
|
60
|
42 (70)
|
|
PIP 2nd
|
13
|
13
|
1
|
33
|
60
|
46 (77)
|
|
PIP 3rd
|
13
|
11
|
3
|
33
|
60
|
46 (77)
|
|
PIP 4th
|
12
|
7
|
1
|
40
|
60
|
52 (87)
|
|
PIP 5th
|
6
|
11
|
1
|
42
|
60
|
48 (80)
|
|
Total
|
103
|
91
|
18
|
268
|
480
|
371 (77)
|
- The number of examined joints is higher than in the other tables because ultrasonography and clinical examination were performed on all finger joints, whereas MRI data were not available in 47 joints. All study participants included. Ultrasonography detecting signs of synovitis and/or joint effusion. Clinical joint assessment detecting swelling and/or tenderness. MCP, metacarpophalangeal; PIP, proximal interphalangeal; US, ultrasonography.
